HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
FRRS1L
ferric chelate reductase 1 like
Chromosome 9 Β· 9q31.3
NCBI Gene: 23732Ensembl: ENSG00000260230.5HGNC: HGNC:1362UniProt: Q9P0K9
14PubMed Papers
21Diseases
0Drugs
39Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
regulation of glutamate receptor signaling pathwayregulation of postsynaptic membrane neurotransmitter receptor levelsendoplasmic reticulum membranepostsynapsegenetic developmental and epileptic encephalopathychoreaProgressive encephalopathySeizure
✦AI Summary

FRRS1L (ferric chelate reductase 1 like) functions as an auxiliary regulatory protein for AMPA receptors, playing a crucial role in glutamatergic signaling and synaptic transmission 1. The protein is essential for AMPA receptor biogenesis and trafficking, facilitating proper maturation and postsynaptic membrane localization of AMPA receptor subunits GLUA2 and GLUA4 1. FRRS1L is highly expressed in the cerebellum and other motor control regions, where it regulates excitatory synaptic transmission 2. Loss-of-function mutations in FRRS1L cause developmental and epileptic encephalopathy-37 (DEE37), characterized by early-onset intractable seizures, severe developmental delay, hyperkinetic movement disorders including choreoathetosis, and cerebellar ataxia 34. The disease mechanism involves reduced AMPA receptor levels and incomplete receptor maturation, leading to impaired glutamatergic signaling 1. Patients typically present with infantile spasms progressing to Lennox-Gastaut syndrome, developmental regression, and continuous spikes-and-waves during sleep (CSWS) 5. Recent research suggests FRRS1L may also play a role in social memory and behavior, with knockout mice showing specific deficits in social novelty recognition 6.

Sources cited
1
FRRS1L functions as auxiliary regulatory protein for AMPA receptors and is essential for receptor biogenesis and maturation
PMID: 30692144
2
FRRS1L is highly expressed in cerebellum and motor control regions, regulating excitatory synaptic transmission
PMID: 36330921
3
Loss-of-function mutations cause DEE37 with seizures, developmental delay, and movement disorders
PMID: 32928027
4
Clinical presentation includes intractable seizures and choreoathetosis
PMID: 34483011
5
Disease progression involves infantile spasms evolving to Lennox-Gastaut syndrome and CSWS
PMID: 35815844
6
FRRS1L plays a role in social memory and behavior based on mouse knockout studies
PMID: 39753649
Disease Associationsβ“˜21
genetic developmental and epileptic encephalopathyOpen Targets
0.73Strong
choreaOpen Targets
0.47Moderate
Progressive encephalopathyOpen Targets
0.47Moderate
SeizureOpen Targets
0.47Moderate
genetic disorderOpen Targets
0.41Moderate
developmental and epileptic encephalopathyOpen Targets
0.37Weak
autosomal recessive non-syndromic intellectual disabilityOpen Targets
0.37Weak
obesityOpen Targets
0.32Weak
ovarian dysfunctionOpen Targets
0.28Weak
type 2 diabetes mellitusOpen Targets
0.15Weak
epilepsyOpen Targets
0.12Weak
injuryOpen Targets
0.11Weak
diabetes mellitusOpen Targets
0.10Weak
metabolic syndromeOpen Targets
0.09Suggestive
Abnormality of the skeletal systemOpen Targets
0.07Suggestive
major depressive disorderOpen Targets
0.06Suggestive
dystonia 31Open Targets
0.04Suggestive
Landau-Kleffner syndromeOpen Targets
0.04Suggestive
Rolandic epilepsyOpen Targets
0.04Suggestive
behavioral variant of frontotemporal dementiaOpen Targets
0.04Suggestive
Developmental and epileptic encephalopathy 37UniProt
Pathogenic Variants39
NM_014334.4(FRRS1L):c.566del (p.Pro189fs)Pathogenic
Developmental and epileptic encephalopathy, 37|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 189
NM_014334.4(FRRS1L):c.584_586del (p.Gly195del)Pathogenic
Developmental and epileptic encephalopathy, 37|Progressive encephalopathy;Seizure;Chorea|not provided|Inborn genetic diseases|FRRS1L-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 195
NM_014334.4(FRRS1L):c.486C>A (p.Cys162Ter)Pathogenic
Developmental and epileptic encephalopathy, 37|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 162
NM_014334.4(FRRS1L):c.721C>T (p.Arg241Ter)Pathogenic
Developmental and epileptic encephalopathy, 37|FRRS1L-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 241
NM_014334.4(FRRS1L):c.283dup (p.Ile95fs)Pathogenic
Developmental and epileptic encephalopathy, 37|Chorea;Progressive encephalopathy;Seizure
β˜…β˜…β˜†β˜†2025β†’ Residue 95
NM_014334.4(FRRS1L):c.246dup (p.Phe83fs)Pathogenic
not provided|Developmental and epileptic encephalopathy, 37
β˜…β˜…β˜†β˜†2024β†’ Residue 83
NM_014334.4(FRRS1L):c.517C>T (p.Gln173Ter)Pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜…β˜†β˜†2024β†’ Residue 173
NM_014334.4(FRRS1L):c.583G>T (p.Gly195Ter)Pathogenic
Developmental and epileptic encephalopathy, 37|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 195
NM_014334.4(FRRS1L):c.808C>T (p.Gln270Ter)Pathogenic
Developmental and epileptic encephalopathy, 37|Seizure;Chorea;Progressive encephalopathy
β˜…β˜…β˜†β˜†2024β†’ Residue 270
NM_014334.4(FRRS1L):c.-78G>TPathogenic
not provided|Developmental and epileptic encephalopathy, 37
β˜…β˜…β˜†β˜†2023
NM_014334.4(FRRS1L):c.310A>G (p.Lys104Glu)Likely pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2026β†’ Residue 104
NM_014334.4(FRRS1L):c.-99delPathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2026
NM_014334.4(FRRS1L):c.543G>A (p.Trp181Ter)Pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2025β†’ Residue 181
NM_014334.4(FRRS1L):c.116dup (p.Arg40fs)Likely pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2025β†’ Residue 40
NM_014334.4(FRRS1L):c.145del (p.Asp49fs)Pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2025β†’ Residue 49
NM_014334.4(FRRS1L):c.327del (p.Arg108_Tyr109insTer)Pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2025β†’ Residue 108
NC_000009.12:g.109167267delPathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2025
NM_014334.4(FRRS1L):c.239-2A>GLikely pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2025
NM_014334.4(FRRS1L):c.189C>G (p.Tyr63Ter)Pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2025β†’ Residue 63
NM_014334.4(FRRS1L):c.321del (p.Phe107fs)Pathogenic
Developmental and epileptic encephalopathy, 37
β˜…β˜†β˜†β˜†2024β†’ Residue 107
View on ClinVar β†—
Related Genes
DAP3Protein interaction100%MRPS5Protein interaction100%MRPS15Protein interaction100%MRPS6Protein interaction100%MRPS16Protein interaction100%MRPL16Protein interaction100%
Tissue Expression6 tissues
Brain
100%
Ovary
82%
Heart
14%
Liver
1%
Lung
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
FRRS1LDAP3MRPS5MRPS15MRPS6MRPS16MRPL16
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q9P0K9
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.41LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.87 [0.56–1.41]
RankingsWhere FRRS1L stands among ~20K protein-coding genes
  • #15,867of 20,598
    Most Researched14
  • #1,579of 5,498
    Most Pathogenic Variants39
  • #14,580of 17,882
    Most Constrained (LOEUF)1.41
Genes detectedFRRS1L
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Early molecular layer interneuron hyperactivity triggers Purkinje neuron degeneration in SCA1.
PMID: 37321222
Neuron Β· 2023
1.00
2
Emerging Monogenic Complex Hyperkinetic Disorders.
PMID: 29086067
Curr Neurol Neurosci Rep Β· 2017
0.90
3
Loss of
PMID: 30692144
Dis Model Mech Β· 2019
0.80
4
Movement disorder caused by FRRS1L deficiency may be associated with morphological and functional disorders in Purkinje cells.
PMID: 36330921
Brain Res Bull Β· 2022
0.70
5
Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy.
PMID: 34483011
Brain Dev Β· 2022
0.60